User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

SFPO and ESOP recommendations for the practical stability of anticancer drugs: An update.

Primary tabs

Vigneron, J Astier, A Trittler, R Hecq, Jean-Daniel [UCL] Daouphars, M Pinguet, F

The recommandations for the practical stability of anticancer drugs published in 2010 by the French Society of Hospital Pharmacists (SFPO) and the European Society of Oncology Pharmacists (ESOP) have been updated. Ten new molecules have been included (asparaginase, azacitidine, bevacizumab, clofarabine, eribuline mesylate, folinate sodium, levofolinate calcium, nelarabine, rituximab, temsirolimus).

Document type Article de périodique (Journal article) – Article de recherche
Access type Accès restreint
Publication date 2013
Language Anglais
Journal information "Annales Pharmaceutiques Francaises" - Vol. 71, no.6, p. 376-389 (2013)
Publisher Elsevier Masson ((France) Issy les Moulineaux)
issn 0003-4509
Publication status Publié
Affiliations UCL - (MGD) Département de pharmacie
UCL - SSS/IREC/MONT - Pôle Mont Godinne
Links
Bibliographic reference Vigneron, J ; Astier, A ; Trittler, R ; Hecq, Jean-Daniel ; Daouphars, M ; et. al. SFPO and ESOP recommendations for the practical stability of anticancer drugs: An update.. In: Annales Pharmaceutiques Francaises, Vol. 71, no.6, p. 376-389 (2013)
Permanent URL http://hdl.handle.net/2078.1/135692